This is a TUGS multinational audit aiming to analyze the 90-day Mortality and Morbidity of patients undergoing esophageal and junctional cancer elective surgery

Joined December 2021
12 Photos and videos
Dear colleagues, The OUTLIVE STUDY has reached 300 collaborators worldwide! This will be one of the biggest studies on esophageal surgery. Even though the study started on April 2022, you are still on time to become part of this huge collaborative audit. lnkd.in/dAminzq7
3
2
9
Please help us share this project. The more collaborators we are the bigger the project will be. @juliomayol @kmahawar @A_Martinino @Vignesh07883426 @Ali_Aminian_MD @AmiraSis @OesophagealCF @ESSOnews @PouwelsSjaak @c9marques @TUGSESTgroup @TugsIndia21 @TROGS_TUGS @DOTEsophagus
2
2
Dear doctors: The Outlive study will surely become one of the biggest collaborative audits on esophageal elective cancer surgery. Do not miss the chance to become an author. You are still on time to join !! forms.gle/YFh83Ly7bJ3EBxc19
10
10
22
Dear doctors: Do not miss the opportunity to participate in one of the biggest collaborative studies on esophageal elective cancer surgery. Although the Outlive study started three weeks ago, you are still on time to participate. forms.gle/YFh83Ly7bJ3EBxc19
2
4
7
It is an audit rather than a trial. Excuse us for this mistake.
We are almost 300 collaborators! This is a huge milestone! We need your help to make this study even bigger! Share it through your network! Bear in mind that increasing the number of collaborators will also increase the likelihood of publishing this study in a high IF journal.
3
6
8
The OUTLIVE study will start today ! Do not miss the opportunity to participate in one of the biggest collaborative studies on esophageal elective cancer surgery. You can participate by clicking on this link: forms.gle/YFh83Ly7bJ3EBxc19
12
9
14